Electroacupuncture at Zusanli (ST36), Guanyuan (CV4), and Qihai (CV6) Acupoints Regulates Immune Function in Patients with Sepsis Via the PD-1 Pathway

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2022 Jul 21

PMID 35860804

Authors

Guang Yang

Bojun Zheng

Yi Yu

Jing Huang

Hongfa Zhu

Dingwei Deng

Jian Li

Affiliations

Soon will be listed here.

Abstract

Objective: The present study is aimed at investigating the biochemical and clinical effects of electroacupuncture in patients with sepsis.

Methods: Patients with sepsis treated at Guangdong Provincial Hospital of Chinese Medicine from July 2019 to December 2020 were included. Patients were randomly assigned to treatment with routine Western medicine (WM group) or treatment with Western medicine plus electroacupuncture based on Western medicine (EA group). Indices associated with immune function and clinical efficacy were determined before and at 3 and 5 days after treatment. Indicators of immune function included the percentage of T lymphocyte subsets, natural killer (NK) cells, and soluble programmed death protein 1 (sPD-1) levels. Indicators of clinical efficacy included infection-related indicators in whole blood; levels of tumor necrosis factor- (TNF-), C-reactive protein (CRP), and interferon- (INF-); and assessments using acute physiology and chronic health evaluation-II (APACHE-II) and sequential organ failure assessment (SOFA) scores.

Results: Baseline data were not different between WM ( = 30) and EA groups ( = 30). At day 5 following treatment, the level of sPD-1 in the EA group was lower than that in the WM group. Proportions of CD3 + T lymphocytes, CD4 + T lymphocytes, and NK cells, the percentage of lymphocytes, and INF- levels in the EA group were significantly higher than those in the WM group. Compared with the WM group, the white blood cell count (WBC), percentage and count of neutrophils, ratio of neutrophils to lymphocytes, and levels of CRP and TNF- were significantly decreased in the EA group 5 days after treatment. The APACHE-II score of the EA group was significantly lower than that of the WM group 5 days after treatment.

Conclusion: Electroacupuncture may regulate the immune function of patients with sepsis through the PD-1 pathway to achieve an anti-inflammatory state and improve clinical symptoms.

Citing Articles

Retracted: Electroacupuncture at Zusanli (ST36), Guanyuan (CV4), and Qihai (CV6) Acupoints Regulates Immune Function in Patients with Sepsis via the PD-1 Pathway.

International B Biomed Res Int. 2024; 2024:9832793.

PMID: 38550204 PMC: 10977203. DOI: 10.1155/2024/9832793.

The implication of targeting PD-1:PD-L1 pathway in treating sepsis through immunostimulatory and anti-inflammatory pathways.

Chen Y, Guo D, Zhu C, Ren S, Sun C, Wang Y Front Immunol. 2024; 14:1323797.

PMID: 38193090 PMC: 10773890. DOI: 10.3389/fimmu.2023.1323797.

Revealing the biological mechanism of acupuncture in alleviating excessive inflammatory responses and organ damage in sepsis: a systematic review.

Yang L, Zhou D, Cao J, Shi F, Zeng J, Zhang S Front Immunol. 2023; 14:1242640.

PMID: 37753078 PMC: 10518388. DOI: 10.3389/fimmu.2023.1242640.

Application and Effectiveness of Chinese Medicine in Regulating Immune Checkpoint Pathways.

Xiong L, Tian Y, Zhai C, Li W Chin J Integr Med. 2023; 29(11):1045-1056.

PMID: 37580466 DOI: 10.1007/s11655-023-3743-8.

Bioelectronic medicine for restoring autonomic balance in autoimmune diseases.

Pikov V Gut Microbiota Integr Wellness. 2023; 1(2).

PMID: 37155473 PMC: 10125261. DOI: 10.54844/gmiw.2022.0182.

References

Bommarito D, Hall C, Taams L, Corrigall V . Inflammatory cytokines compromise programmed cell death-1 (PD-1)-mediated T cell suppression in inflammatory arthritis through up-regulation of soluble PD-1. Clin Exp Immunol. 2017; 188(3):455-466. PMC: 5422858. DOI: 10.1111/cei.12949. View

Hotchkiss R, Monneret G, Payen D . Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013; 13(12):862-74. PMC: 4077177. DOI: 10.1038/nri3552. View

Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M . The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10. PMC: 4968574. DOI: 10.1001/jama.2016.0287. View

Vivier E, Artis D, Colonna M, Diefenbach A, Di Santo J, Eberl G . Innate Lymphoid Cells: 10 Years On. Cell. 2018; 174(5):1054-1066. DOI: 10.1016/j.cell.2018.07.017. View

Niu M, Liu Y, Yi M, Jiao D, Wu K . Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer. Front Immunol. 2022; 13:827921. PMC: 8977417. DOI: 10.3389/fimmu.2022.827921. View

Bone R, Grodzin C, Balk R . Sepsis: a new hypothesis for pathogenesis of the disease process. Chest. 1997; 112(1):235-43. DOI: 10.1378/chest.112.1.235. View

Xie D, Zhou G, Chen R, Qin X, Du J, Zhang Y . Effect of Electroacupuncture at Zusanli (ST36) on Sepsis Induced by Cecal Ligation Puncture and Its Relevance to Spleen. Evid Based Complement Alternat Med. 2020; 2020:1914031. PMC: 7563055. DOI: 10.1155/2020/1914031. View

Saraswati W, Dahlan E, Saputra K, Sutrisno T . Effect of Electroacupuncture on Natural-Killer Cells and Tumor Size in Patients with Cervical Squamous-Cell Carcinoma: A Randomized Controlled Trial. Med Acupunct. 2019; 31(1):29-36. PMC: 6386775. DOI: 10.1089/acu.2018.1316. View

Doughty L . Adaptive immune function in critical illness. Curr Opin Pediatr. 2016; 28(3):274-80. DOI: 10.1097/MOP.0000000000000357. View

10.

Xiao Q, Ma M, Zhang X, Deng M, Yang Yan Z . [Effect of Acupuncture on Prognosis and Immune Function of Sepsis Patients]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2015; 35(7):783-6. View

11.

Hutchins N, Unsinger J, Hotchkiss R, Ayala A . The new normal: immunomodulatory agents against sepsis immune suppression. Trends Mol Med. 2014; 20(4):224-33. PMC: 3976785. DOI: 10.1016/j.molmed.2014.01.002. View

12.

Lang J, Matute-Bello G . Lymphocytes, apoptosis and sepsis: making the jump from mice to humans. Crit Care. 2009; 13(1):109. PMC: 2688100. DOI: 10.1186/cc7144. View

13.

Bosmann M, Ward P . The inflammatory response in sepsis. Trends Immunol. 2012; 34(3):129-36. PMC: 3543471. DOI: 10.1016/j.it.2012.09.004. View

14.

Lai F, Ren Y, Lai C, Chen R, Yin X, Tan C . Acupuncture at Zusanli (ST36) for Experimental Sepsis: A Systematic Review. Evid Based Complement Alternat Med. 2020; 2020:3620741. PMC: 7081026. DOI: 10.1155/2020/3620741. View

15.

Pesce S, Greppi M, Tabellini G, Rampinelli F, Parolini S, Olive D . Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization. J Allergy Clin Immunol. 2016; 139(1):335-346.e3. DOI: 10.1016/j.jaci.2016.04.025. View

16.

Chiche L, Forel J, Thomas G, Farnarier C, Cognet C, Guervilly C . Interferon-γ production by natural killer cells and cytomegalovirus in critically ill patients. Crit Care Med. 2012; 40(12):3162-9. DOI: 10.1097/CCM.0b013e318260c90e. View

17.

Concha-Benavente F, Kansy B, Moskovitz J, Moy J, Chandran U, Ferris R . PD-L1 Mediates Dysfunction in Activated PD-1 NK Cells in Head and Neck Cancer Patients. Cancer Immunol Res. 2018; 6(12):1548-1560. PMC: 6512340. DOI: 10.1158/2326-6066.CIR-18-0062. View

18.

Hsu J, Hodgins J, Marathe M, Nicolai C, Bourgeois-Daigneault M, Trevino T . Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade. J Clin Invest. 2018; 128(10):4654-4668. PMC: 6159991. DOI: 10.1172/JCI99317. View

19.

Chang K, Svabek C, Vazquez-Guillamet C, Sato B, Rasche D, Wilson S . Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Crit Care. 2014; 18(1):R3. PMC: 4056005. DOI: 10.1186/cc13176. View

20.

Patil N, Guo Y, Luan L, Sherwood E . Targeting Immune Cell Checkpoints during Sepsis. Int J Mol Sci. 2017; 18(11). PMC: 5713381. DOI: 10.3390/ijms18112413. View